The real-world comparison of non-small cell lung cancer survival outcomes depending on immunotherapy treatment and PD-L1 expression level.

Autor: Ondrušová M; Pharm-In, Ltd., Bratislava, Slovakia.; Faculty of Public Health, Slovak Medical University, Bratislava, Slovakia., Suchanský M; Pharm-In, Ltd., Bratislava, Slovakia., Vándor Svidová S; Pharm-In, Ltd., Bratislava, Slovakia., Chowaniecová G; Specialized Hospital of St. Zoerardus, Nitra, Slovakia., Mriňáková B; 1st Department of Oncology, Comenius University, Faculty of Medicine and St. Elisabeth Cancer Institute, Bratislava, Slovakia., Sekerešová M; Department of Pathology, Faculty Hospital Nitra, Nitra, Slovakia., Juskanič D; JESSENIUS-Diagnostic Center, Nitra, Slovakia.; Faculty of Medicine, Slovak Medical University, Bratislava, Slovakia., Ondruš D; 1st Department of Oncology, Comenius University, Faculty of Medicine and St. Elisabeth Cancer Institute, Bratislava, Slovakia., Šenitko M; Division of Pulmonary and Critical Care Medicine, University of Mississippi Medical Center, Jackson, Mississippi, United States.; Hospital Bory, Bratislava, Slovakia.

Publikováno v: Neoplasma [Neoplasma] 2024 Oct; Vol. 71 (5), pp. 498-508.

EP1.04-19 First Experience with Atezolizumab in Slovakia

Autor: Kasan, P., Berzinec, P., Cerna, M., Andrasina, I., Cipkova, A., Chowaniecova, G., Denkova, L., Godal, R., Kuzmova, H., Svihelova – Liskova, Z., Martak, M., Mazal, J., Obertova, J., Pribulova, Z., Urda, M., Vesela, M.

Publikováno v: In Journal of Thoracic Oncology October 2019 14(10) Supplement:S970-S970

P2.03-056 Primary Double EGFR Mutations T790M and Mutation in Exon 19 or 21 in Slovakiab NSCLC Patients - Updated Survival Data

Autor: Berzinec, P., Kasan, P., Godal, R., Plank, L., Copakova, L., Alemayehu, A., Chowaniecova, G., Farkasova, A., Hlavcak, P., Kucma, M., Rotikova, L., Slavikova, M., Vasovcak, P.

Publikováno v: In Journal of Thoracic Oncology November 2017 12(11) Supplement 2:S2396-S2396

EGFR mutations in squamous NSCLC – Prevalence and treatment results with EGFR tyrosine kinase inhibitors (TKIs) in patients from western Slovakia

Autor: Berzinec, P., Hlinkova, K., Copakova, L., Konecny, M., Zavodna, K., Cerna, M., Culagova, M., Chowaniecova, G., Babal, P.

Publikováno v: In Lung Cancer June 2012 77 Supplement 1:S21-S21

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.